Hopital Maisonneuve-Rosemont

Hopital Maisonneuve-Rosemont, a tax-exempt Canadian hospital entity based in Montréal, participates in federally funded medical research as a sub-recipient on grants administered by the National Institutes of Health, with no direct federal prime contracting or grant-recipient activity in the source data.

The organization's federal footprint is confined to three sub-award grants, all placed within the past two years and totaling $212 thousand in obligated dollars. Two awards fund nephrology research under the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), with prime grantees at the University of North Carolina at Chapel Hill. In the more recent award (December 2025), Hopital Maisonneuve-Rosemont participates as one of seven nephrology programs in a collaborative effort to establish long-term clinical observation of a cohort of 300 patients with diabetes and biopsy-proven glomerulonephritis kidney disease (including IgA nephropathy, focal segmental glomerulosclerosis, membranous glomerulonephritis, and minimal-change disease), with the goal of creating a biorepository of serum, plasma, urine, and DNA samples. The earlier NIDDK sub-award (November 2024) describes similar work across a larger cohort of 600 patients across four glomerulonephritis forms, involving serial clinic visits, interval clinical histories, physical examinations, and specimen collection. A third sub-award from February 2024, prime-grantee Rutgers University and funded by the National Institute on Aging, covers single-nuclei multiomic analysis of diffuse Lewy body (DLB) disease progression. No parent vehicles, IDIQs, or teaming relationships appear in the source data. Activity has been sparse and recent — two awards in 2024 and one in 2025 — with no recompete cliff identified. Hopital Maisonneuve-Rosemont operates as a research hospital site, not as a federal contractor or grant administrator, and serves primarily as a patient-enrollment and specimen-collection partner within NIH-funded consortium research programs led by U.S. universities.